CMN-008

N/A

Report date: 2023/06/27 18:00:10

Base Information

Drug NameCMN-008
Drug Alias NameCMN-008
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoImmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoImmune Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A